(Q22251106)

6 February 2023

10

Asma Nusrat

Asma

Nusrat

1 reference

6 February 2023

Maiko Sasaki

1

Maiko

Sasaki

1 reference

6 February 2023

Shanti V Sitaraman

2

Shanti V

Sitaraman

1 reference

6 February 2023

Brian A Babbin

3

Brian A

Babbin

1 reference

6 February 2023

Efrain M Ribot

5

Efrain M

Ribot

1 reference

6 February 2023

Nancy Garrett

6

Nancy

Garrett

1 reference

6 February 2023

Joel A Alpern

7

Joel A

Alpern

1 reference

6 February 2023

Adil Akyildiz

8

Adil

Akyildiz

1 reference

6 February 2023

Arianne L Theiss

9

Arianne L

Theiss

1 reference

6 February 2023

Jan-Michael A Klapproth

11

Jan-Michael A

Klapproth

1 reference

Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor.

6 February 2023

language of work or name

English

0 references

publication date

30 July 2007

0 references

published in

Laboratory Investigation

0 references

volume

87

0 references

issue

10

0 references

page(s)

1042-1054

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

TLR signaling in the gut in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

Inflammatory bowel disease: etiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Clinical aspects and pathophysiology of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Cytokines in Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Tissue cytokine and chemokine expression in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Clinical and microbiologic features of Shigella and enteroinvasive Escherichia coli infections detected by DNA hybridization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Inflammatory bowel disease is associated with changes of enterocytic junctions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Influence of inflammatory bowel disease on intestinal microflora

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Bacterial DNA within granulomas of patients with Crohn's disease--detection by laser capture microdissection and PCR.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Mucosal flora in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

TNF alpha production to TLR2 ligands in active IBD patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700661

7 January 2021

10.1038/LABINVEST.3700661

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_4e23odumhrdudfaxbw56cea5ri

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4e23odumhrdudfaxbw56cea5ri

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17660846

1 reference

Consolidated OpenCitations Corpus – April 2017